Veeva Systems APAC’s Post

Looking forward to sharing some of my own thoughts and hearing yours too on a topic close to my heart - “Building the foundation of data driven engagement” at the Veeva India Summit on 24th Oct in Mumbai, India. See you there! #VeevaIndiaCommercialSummit #Data #FoundationforCX #NextGenCustomerEngagement

Register today for an insightful session on Future Engagement Models in the Pharma industry!

Combining human expertise with technology can be an agile and cost-effective option for pharmacovigilance and regulatory affairs outsourcing. Using just one vendor can streamline this process. IQVIA leaders, Alison Sekikawa and Annette Williams, are leading the way in this combined approach. This innovative outsourcing strategy is not only effective but also gaining traction. A growing number of pharma and biotech companies are planning to adopt it. Don’t just take their word for it, read the numerous research reports and white papers at our new integrated compliance hub: https://bit.ly/3xUSUGx #phamacovigilance #regulatoryaffairs #pharmaoutsourcing #biotech

Pharma enterprises are facing major shifts in clinical operations. Join us live to explore 2024’s biggest challenges, tech-driven transformations, and evolving sourcing strategies for 2025. Register: https://okt.to/TWFSOd

This month we are pleased to share an interview published in the The Irish Times as part of our commitment to the Pharma Industry Awards, where we serve as 'Impact Ambassador for Digital Innovation.' The Q&A includes insights from David Sheedy, Head of Life Sciences Manufacturing Ireland, and David Staunton, Head of Transformation for Cognizant, and discusses the latest trends and challenges in pharma manufacturing. Our leaders highlight the critical role of digital innovation and technology in driving industry advancements, emphasizing the importance of a data-centric approach to improve the economics of drug manufacturing. The interview also explores the potential of hashtag#generativeAI to make personalized therapies more accessible and affordable, along with the factors contributing to genuine innovation in the field. Additionally, they discuss ongoing digital transformation in the industry, driven by technology integration, and offer a forward-looking perspective on the emerging technologies set to shape the next decade. Read the full interview here: https://cogniz.at/3BPplIr #digitalinnovation #pharmaindustryawards #irelandpharma

Combining human expertise with technology can be an agile and cost-effective option for pharmacovigilance and regulatory affairs outsourcing. Using just one vendor can streamline this process. IQVIA leaders, Alison Sekikawa and Annette Williams, are leading the way in this combined approach. This innovative outsourcing strategy is not only effective but also gaining traction. A growing number of pharma and biotech companies are planning to adopt it. Don’t just take their word for it, read the numerous research reports and white papers at our new integrated compliance hub: https://bit.ly/44pgLuw #phamacovigilance #regulatoryaffairs #pharmaoutsourcing #biotech

Combining human expertise with technology can be an agile and cost-effective option for pharmacovigilance and regulatory affairs outsourcing. Using just one vendor can streamline this process. IQVIA leaders, Alison Sekikawa and Annette Williams, are leading the way in this combined approach. This innovative outsourcing strategy is not only effective but also gaining traction. A growing number of pharma and biotech companies are planning to adopt it. Don’t just take their word for it. Read the numerous research reports and white papers at our new integrated compliance hub: https://bit.ly/3VWck88 #phamacovigilance #regulatoryaffairs #pharmaoutsourcing #biotech

Pharma companies are rethinking their clinical operations strategies. Learn how evolving technology and market dynamics will impact sourcing strategies in 2025. Join us for a LinkedIn Live session to explore major challenges and emerging trends. Save your place: https://okt.to/2PQek6

Is your clinical trial process 𝘀𝘁𝘂𝗰𝗸 𝗶𝗻 𝗻𝗲𝘂𝘁𝗿𝗮𝗹? It's time to 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲. 𝗥𝗲𝘃𝗮𝗺𝗽 𝗬𝗼𝘂𝗿 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝘄𝗶𝘁𝗵 𝗜𝗤𝗩𝗜𝗔 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗗𝗮𝘆 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘 𝗘𝘂𝗿𝗼𝗽𝗲 2024𝗅 Join us at the 𝗜𝗤𝗩𝗜𝗔 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗗𝗮𝘆 𝗮𝘁 𝗦𝗖𝗢𝗣𝗘 𝗘𝘂𝗿𝗼𝗽𝗲 2024 for a complimentary afternoon of game-changing insights and solutions. 𝗛𝗲𝗿𝗲'𝘀 𝘄𝗵𝗮𝘁 𝗮𝘄𝗮𝗶𝘁𝘀 𝘆𝗼𝘂: 𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗘𝗱𝗴𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: Get a glimpse into the future of clinical research with presentations from IQVIA's digital product leaders. 𝗜𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗗𝗲𝗺𝗼𝘀: Experience firsthand how IQVIA's innovative technologies can streamline your workflows, improve patient engagement, and boost site efficiency. 𝗢𝗽𝗲𝗻 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻: Challenge industry experts with your questions and learn from the experiences of your peers at the "𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗙𝗼𝗿𝘂𝗺." 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀: Connect with other clinical trial professionals, build meaningful relationships, and explore potential collaborations. 𝗧𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝘀 𝗶𝗱𝗲𝗮𝗹 𝗳𝗼𝗿: Pharmaceutical executives Trial managers Medical directors Business operations professionals Patient or site engagement specialists Strategic sourcing leads Register today for IQVIA Innovation Day at SCOPE Europe 2024: https://lnkd.in/gqA9ZnwB hashtag #IQVIAInnovationDay hashtag #SCOPEEurope hashtag #ClinicalTrials hashtag #Innovation hashtag #ClinicalOperations hashtag #Networking

Which pharma company is the most digitally present in Belgium? According to the 'Worldcom Pharma Digital Monitor 2024', Janssen (part of J&J) pays tribute to its local heritage also online, demonstrating the most extensive digital presence to interact with the general public across channels (e.g. website, blogs, social media) in Belgium. Together with further international pharma leaders, another Belgian front-runner shows up high in the ranking, namely UCB. On the other side of the spectrum, a relatively large number of pharmaceutical companies limits their digital presence to their website without being actively present on social media etc. What is holding some companies back from broader channel use: - Regulatory hurdles in direct-to-patient interaction? - Restricted cross-affiliate support and technical backbone to locally build-out their digital presence? - Challenges in continued content generation and limited applicable global input to be leveraged? - Absence of or limited experience with AI tools for channel orchestration? - Potentially limited expected return on investments in further channels or social media campaigns? - What else? Curious to hear your thoughts! Roland Berger Belgium happily supports local and international Pharmaceutical players navigate their most critical challenges. Please feel free to contact our experts: Grégoire Tondreau Astrid Böhlke Maxime Descy Michael Baur #RolandBerger #RBHealthBelgium #Innovation #Pharma #LifeScience #Belgium